Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Forgoing of end of life treatment varies in European countries

01.03.2005


The frequency of withholding or withdrawing life-prolonging treatment at the end of a patient’s life varied greatly among six European countries, according to an article in the February 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.



"Modern medicine provides unprecedented opportunities in diagnostics and treatment to save and sustain life," according to background information in the article. However, in certain situations at the end of a patient’s life, physicians may refrain from using all possible treatments to prolong life.

Georg Bosshard, M.D., M.A.E., from the University of Zurich, Switzerland, and colleagues studied different types of treatment withheld or withdrawn from patients in six European countries between June 2001 and February 2002. Physicians were sent questionnaires about their decision-making process of the patients’ treatment. They were asked whether or not they withheld or withdrew medical treatment and if so, what kind of treatment.


The researchers found marked differences in the occurrence of end-of-life nontreatment decisions in the participating countries. Decisions not to treat were reported for 41 percent of deaths in Switzerland, 30 percent in the Netherlands, 27 percent in Belgium, 23 percent in Denmark, 22 percent in Sweden, and 6 percent in Italy. Medication was the treatment most frequently forgone in all of the countries studied except Italy, making up 54 percent of treatments forgone in Denmark, 48 percent in Switzerland, 42 percent in Belgium, 38 percent in the Netherlands, 37 percent in Sweden. Forgoing hydration or nutrition treatment was also common, occurring in 22 percent of the cases studied.

"In all of the participating countries, life-prolonging treatment is withheld or withdrawn at the end of life," the authors write. "Low-technology interventions, such as medication or hydration or nutrition, are most frequently forgone. In older patients and outside the hospital, physicians prefer not to initiate life-prolonging treatment at all rather than stop it later."

Georg Bosshard, M.D. | EurekAlert!
Further information:
http://www.unizh.ch
http://www.jama.ama-assn.org
http://www.archinternmed.com)

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>